Riluzole and Cerebral Glucose Metabolism in Alzheimer Disease
This study indicates that the glutamate modulator riluzole slows decline of cerebral glucose metabolism in patients with Alzheimer disease, as measured by FDG-PET. Might it be an effective AD therapy?